Literature DB >> 6293880

Coordination of cardiac sarcoplasmic reticulum and myofibrillar function by protein phosphorylation.

E G Kranias, R J Solaro.   

Abstract

Adrenergic stimulation alters functional dynamics of the heart by mechanisms most likely involving cyclic AMP (cAMP)-dependent protein phosphorylation. In vitro studies indicate that the myofibrils and sarcoplasmic reticulum (SR) may act as effectors of the adrenergic stimulation. cAMP-dependent phosphorylation of troponin I (TnI), one of the regulatory proteins of cardiac myofibrils, results in a decreased steady-state affinity of troponin C (TnC) for calcium, an increase in the off-rate for Ca2+ exchange with TnC, and a rightward shift of the relation between free Ca2+ and myofibrillar force or ATPase. Phosphorylation of phospholamban, a regulatory protein of cardiac SR, results in an increased velocity of Ca2+ transport by SR vesicles, an increased affinity of the transport protein for Ca2+, and an increased turnover of elementary steps of the ATPase reaction. These in vitro findings support the hypothesis that the inotropic response of the heart to catecholamine stimulation involves phosphorylation of TnI and phospholamban. Our in vivo studies with perfused rabbit hearts show that during the peak of the inotropic response to isoproterenol there is a simultaneous phosphorylation of TnI and an 11,000-dalton protein in the SR, most likely the monomeric form of phospholamban.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6293880

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  8 in total

1.  Role of ventriculovascular coupling in cardiac response to increased contractility in closed-chest dogs.

Authors:  G L Freeman; J T Colston
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

2.  Cardiac alpha-crystallin. II. Intracellular localization.

Authors:  S Longoni; S Lattonen; G Bullock; M Chiesi
Journal:  Mol Cell Biochem       Date:  1990-09-21       Impact factor: 3.396

3.  The role of phospholamban in the regulation of calcium transport by cardiac sarcoplasmic reticulum.

Authors:  B A Davis; I Edes; R C Gupta; E F Young; H W Kim; N A Steenaart; G Szymanska; E G Kranias
Journal:  Mol Cell Biochem       Date:  1990-12-20       Impact factor: 3.396

Review 4.  Phosphodiesterase inhibition by new cardiotonic agents: mechanism of action and possible clinical relevance in the therapy of congestive heart failure.

Authors:  H von der Leyen
Journal:  Klin Wochenschr       Date:  1989-06-15

5.  Differential roles of regulatory light chain and myosin binding protein-C phosphorylations in the modulation of cardiac force development.

Authors:  Brett A Colson; Matthew R Locher; Tanya Bekyarova; Jitandrakumar R Patel; Daniel P Fitzsimons; Thomas C Irving; Richard L Moss
Journal:  J Physiol       Date:  2010-02-01       Impact factor: 5.182

6.  Phosphorylation and functional modifications of sarcoplasmic reticulum and myofibrils in isolated rabbit hearts stimulated with isoprenaline.

Authors:  E G Kranias; J L Garvey; R D Srivastava; R J Solaro
Journal:  Biochem J       Date:  1985-02-15       Impact factor: 3.857

Review 7.  Can new inodilators displace digitalis in the therapy of congestive heart failure?

Authors:  T Kumada; C Kawai
Journal:  Cardiovasc Drugs Ther       Date:  1989-01       Impact factor: 3.727

8.  In vitro studies of early cardiac remodeling: impact on contraction and calcium handling.

Authors:  Kaylan M Haizlip; Paul M L Janssen
Journal:  Front Biosci (Schol Ed)       Date:  2011-06-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.